Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : The Big Tex House of Coin -- Ignore unavailable to you. Want to Upgrade?

To: BigTex who wrote (8789)	11/12/1999 1:20:00 PM
From: Spark	Respond to of 19297

ROTFL!!

To: BigTex who wrote (8789)	11/12/1999 1:52:00 PM
From: Spark	Read Replies (1) \| Respond to of 19297

You'd think this would fly...maybe it will... BSD Medical Acquires Exclusive License to Tumor-Destroying Hyperthermia Treatment SALT LAKE CITY, Nov. 11 /PRNewswire/ -- BSD Medical Corp. (OTC Bulletin Board: BSDM - news) announces that it has acquired from the University of California San Francisco (UCSF) the exclusive patent license for small microwave antennae that can be inserted into cancerous tumors to destroy them from the inside. This technology is applicable to hyperthermia and thermal therapy techniques. The innovative microwave antenna design enables the therapeutic heating length to be tailored to match the tumor size. Clinical studies have shown a survival improvement when using this technology in combination with radiation brachytherapy. This technology has been shown effective for many cancerous tumors, including brain tumors (P. K. Sneed, International Journal of Radiation Oncology Biology and Physics, 1998, Vo. 40, No. 2, p. 287). Brachytherapy is widely used to provide ''tumor specific'' delivery of radiation therapy. The use of microwave heating in combination with brachytherapy has been shown to improve patient survival without an increase in side effects. Use of the new antenna is expected to improve treatment success with brachytherapy for many tumors. Hyrum Mead, President of BSD Medical states, ''Acquisition of this exclusive patent license from UCSF is a notable addition to our product line and consistent with our strategy to increase the effectiveness of existing cancer therapies. With the addition of this patent, BSD Medical Corporation now enjoys the protection of twenty-two U.S. patents covering all aspects of our products.'' BSD Medical Corporation (BSDM) is the leading developer and manufacturer of hyperthermia systems for cancer therapy, and pioneered the non-surgical treatment of benign diseases of the prostate using microwave energy. For information on the Company, or to find hyperthermic oncology information sources and treatment centers, please visit the BSD Medical Corporation web site (www.bsdmc.com). Statements contained in this press release that are not historical facts are forward looking statements, as that item is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties (detailed in the Company's findings with the Securities and Exchange Commission) that could cause actual results to differ materially from estimated results. SOURCE: BSD Medical Corporation -------------------------------------------------------------------------------- More Quotes and News: BSD Medical Corp (OTC BB:BSDM.OB - news) Related News Categories: medical/pharmaceutical --------------------------------------------------------------------------------

To: BigTex who wrote (8789)	11/15/1999 2:27:00 AM
From: Katie Kommando	Respond to of 19297

Hey Big Tex, I see you like sports over here on this thread . . . Ascent Entertainment (NASDAQ: GOAL) is one to watch closely on Monday. GOAL is trying to sell the Denver Avalanche, Nuggets and the Pepsi Center. Monday is the deadline for the buyer and the City of Denver to come to terms. If the sale goes through then GOAL will be purchased by Liberty Media (NYSE: LMG.A) in a stock deal of .46 shares of Liberty for each share of GOAL. At Liberty's current price GOAL is worth over $19. It is currently trading at about 14 1/2. If we get news of the buyer and the City of Denver coming to terms on Monday GOAL is good for a quick $3 increase. I picked up 3000 shares on Friday in hopes of making a quick 10K. Katie K.